Frontlight ResearchEarly access
Trial site
Uniklinikum Salzburg
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Ulcerative colitis2 trials
- Crohn's disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Kidney cancer1 trial
- Lupus (SLE)1 trial
- Stroke1 trial
- Phase
- Phase 34 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
- Ipsen1 trial
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial
- Microbiotica Ltd1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026